Skip to main content

What Kind of Pancreatic Extracts To Use?

  • Conference paper
Facing the Pancreatic Dilemma

Abstract

Treatment of exocrine pancreatic insufficiency is based on oral administration of pancreatic enzyme-containing preparations. The aim is to prevent or correct malnutrition secondary to exocrine pancreatic insufficiency through a clinically relevant reduction or normalization of faecal fat and nitrogen losses.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Regan PT, Malagelada JR, Di Magno EP, Glanzman SL, Go VLW (1979) Comparative effects of antacids, cimetidine and enteric coating on the therapeutic response to oral enzymes in severe pancreatic insufficiency. N Engl J Med 297:854– 858

    Article  Google Scholar 

  2. Caliari S, Benini L, Bonfante F, Brentegani MT, Fioretta A, Vantini I (1993) Pancreatic extracts are necessary for the absorption of elemental and polymeric diets in severe pancreatic insufficiency. Scand J Gastroenterol 28:749–752

    Article  PubMed  CAS  Google Scholar 

  3. Abrams CK, Hamosh M, Dutta SK, Hubbard VS, Hamosh P (1987) Role of nonpancreatic lipolytic activity in exocrine pancreatic insufficiency. Gastroenterology 92:125–129

    PubMed  CAS  Google Scholar 

  4. Graham DJ (1972) Enzyme replacement therapy of exocrine pancreatic insufficiency. N Engl J Med 296:1314–1317

    Article  Google Scholar 

  5. Mariani A, Bocchia P, Basilico M, Malesci A (1992) Efficacy of a new pancreatic extract in the treatment of steatorrhea due to chronic pancreatitis. Ital J Gastroenterol 24:164

    Google Scholar 

  6. Dobrilla G (1989) Management of chronic pancreatitis. Focus on enzyme replacement therapy. Int J Pancreatol 5:17– 29

    PubMed  Google Scholar 

  7. Marotta F, O’Keefe SJ, Marks IN, Girdwood A, Young G (1989) Pancreatic enzyme replacement therapy. Importance of gastric acid secretion, H2 antagonists and enteric-coating. Dig Dis Sci 3:456 – 461

    Article  Google Scholar 

  8. Linehan JP, Lambert MA, Brown DC, Kurtz AB, Cotton PB, Russell RCG (1988) Total pan-createctomy for chronic pancreatitis. Gut 29:358 –365

    Article  PubMed  CAS  Google Scholar 

  9. Vantini I, Lucchin L, Piubello W, Brocco G, Marchiaro G, Benini L, Cavallini G, Scuro LA (1981) In vitro comparison of enzymatic activities in 19 enzyme-containing commercial preparations marketed in Italy. Ital J Gastroenterol 13:190–192

    CAS  Google Scholar 

  10. Otte M, Gutowski HD, Mackenroth T (1991) In vitro testing of pancreatic enzyme preparations. In: Lankisch PG (ed) Pancreatic enzyme in health and disease. Springer, Berlin Heidelberg New York, pp 65 – 70

    Chapter  Google Scholar 

  11. Beverley DW, Kelleher J, MacDonald A, Littlewood JM, Robinson T, Walters MP (1987) Comparison of four pancreatic extracts in cystic fibrosis. Arch Dis Child 62:564–568

    Article  PubMed  CAS  Google Scholar 

  12. Ruyssen R, Lauwers A (1978) Pharmaceutical enzymes. Story Scientia, Gent, pp 57–84

    Google Scholar 

  13. Reynolds JEF (1989) Martindale. The extra pharmacopoeia, 29th edn. Pharmaceutical Press, London

    Google Scholar 

  14. Thiruvengadam R, Di Magno EP (1988) Inactivation of human lipase by proteases. Am J Physiol 255 : G476 – G481

    PubMed  CAS  Google Scholar 

  15. Pap A, Varro V (1986) Replacement therapy in pancreatic insufficiency with a new pan-creatin preparation as the cause of the excellent results of replacement therapy. Dig Dis Sci 31:519

    Article  Google Scholar 

  16. Pap A, Varro V (1988) Replacement therapy in pancreatic insufficiency with a new pan-creatin preparation respecting the physiological ratio of lipase/trypsin activity. Hepato-gastroenterology 35:83 – 86

    PubMed  CAS  Google Scholar 

  17. Slaff J, Jacobs D, Tillman CR, Currington C, Toskes P (1984) Protease specific suppression of pancreatic exocrine secretion. Gastroenterology 87:44–52

    PubMed  CAS  Google Scholar 

  18. Lankisch PG (1991) Differential treatment of exocrine pancreatic insufficiency in chronic pancreatitis. In: Lankisch PG (ed) Pancreatic enzymes in health and disease. Springer, Berlin Heidelberg New York, pp 191–208

    Chapter  Google Scholar 

  19. Halgreen H, Thorsgaard Pedersen N, Worning H (1986) Symptomatic effect of pancreatic enzyme therapy in patients with chronic pancreatitis. Scand J Gastroenterol 21:104 –108

    Article  PubMed  CAS  Google Scholar 

  20. Isaksson G, Ishe I (1983) Pain reduction by an oral pancreatic enzyme preparation in chronic pancreatitis. Dig Dis Sci 28:97 –102

    Article  PubMed  CAS  Google Scholar 

  21. Slaff J, Jacobson D, Tillman CR, Curington C, Toskes P (1984) Protease specific suppression of pancreatic secretion. Gastroenterology 87:44 –52

    PubMed  CAS  Google Scholar 

  22. Malesci A, Gaia E, Vantini I, Bocchia P, Fioretta A, Ciravegna CP (1990) Effect of pancreatic extract therapy on abdominal pain in chronic pancreatitis: a 4 months double blind crossover study. Gastroenterology 5 : A 228

    Google Scholar 

  23. Mössner J, Secknus R, Meyer J, Niederau C, Adler G (1991) Treatment of pain with pancreatic extracts in chronic pancreatitis. Gastroenterology 100 : A290

    Google Scholar 

  24. Di Magno EP, Go VLW, Summerskill WHJ (1973) Relation between pancreatic enzyme outputs and malabsorption in severe pancreatic insufficiency. N Engl J Med 288:813–815

    Article  Google Scholar 

  25. Lankisch PG, Lembke B, Wemken G, Creutzfeldt W (1986) Functional reserve capacity of the exocrine pancreas. Digestion 35:175 –181

    Article  PubMed  CAS  Google Scholar 

  26. Gaskin KJ, Durie PR, Lee L, Durie PR (1984) Colipase and lipase secretion in childhood-onset pancreatic insufficiency. Gastroenterology 86:1–7

    PubMed  CAS  Google Scholar 

  27. Zerega J, Lerner S, Meyer H (1988) Duodenal instillation of pancreatin does not abolish steatorrhea in patients with pancreatic insufficiency. Dig Dis Sci 33:1245–1249

    Article  PubMed  CAS  Google Scholar 

  28. Kelly DG, Sandberg RJ, Bentley KJ, Zinsmeister AR, Di Magno EP (1988) Protection of lipolytic activity by nutrients in simulated pancreatic insufficiency. Pancreas 3:601

    Google Scholar 

  29. Dekehart MR, Dutta SK, Vaeth J (1989) Dietary fiber supplementation: effect on exocrine pancreatic secretion in man. Am J Clin Nutr 50:1023 –1028

    Google Scholar 

  30. Dutta SK, Hlasko J, (1985) Dietary fiber in pancreatic disease: effect of high fiber diet on fat malabsorption in pancreatic insufficiency and in vitro study of the interaction of dietary fiber with pancreatic enzymes. Am J Clin Nutr 41:517–525

    PubMed  CAS  Google Scholar 

  31. Gullo L, Pezzilli R, Cassano A, Ligabue A, Ventrucci M, Barbara L (1988) Clinical effectiveness of a new enteric-coated pancreatic enzyme extract in the treatment of the pancreatic steatorrhea. Curr Ther Res 44:105 –109

    Google Scholar 

  32. Fioretta A, Bonfante F, Caliari S, Brentegani MT, Scattolini C, Benini L, Vantini I (1992) Effect of a new pancreatic supplement (enteric-coated microtablets) with a very high lipase content on faecal fat excretion in patients with exocrine pancreatic insufficiency. Ital J Gastroenterol 24:160

    Google Scholar 

  33. Elashoff J, Porter-Fink V, Dressman J, Amidon G (1987) What should be the size of pancreatin microspheres? Gastroenterology 92:1533

    Google Scholar 

  34. Vantini I, Fioretta A, Brocco G, Benini L, Sembenini C, Scuro LA (1987) Attività nel lume duodenale di un nuovo preparato contenente enzimi pancreatici. Ter Mod 4:145–150

    Google Scholar 

  35. Dutta SK, Rubin J, Jeffrey H (1983) Comparative evaluation of the therapeutic efficacy of a pH-sensitive enteric coated pancreatic enzyme preparation with conventional pancreatic enzyme therapy in the treatment of exocrine pancreatic insufficiency. Gastroenterology 84:476–482

    PubMed  CAS  Google Scholar 

  36. Regan PT, Malagelada JR, Di Magno EP, Go VLW (1979) Postprandial gastric function in pancreatic insufficiency. Gut 20:249 – 254

    Article  PubMed  CAS  Google Scholar 

  37. Cortot A, Jobin G, Ruskone A, Bernier JJ (1981) Rapid gastric emptying of lipids in pancreatic insufficiency in man. Gastroenterology 80:1129

    Google Scholar 

  38. Long WB, Weiss JB (1974) Rapid gastric emptying of fatty meals in pancreatic insufficiency. Gastroenterology 67:920 – 925

    PubMed  CAS  Google Scholar 

  39. Meyer JH (1991) Delivery of pancreatin in microsphere preparations: transit, timing, physiological needs. In: Lankisch PG (ed) Pancreatic enzymes in health and disease. Springer, Berlin Heidelberg New York, pp 71 – 88

    Chapter  Google Scholar 

  40. Sirois PJ, Amidon GL, Meyer JH, Doty JE, Dressman JB (1990) Size and density discrimination of nondigestible solids during gastric emptying in dogs: a hydrodynamic correlation. Am J Physiol 258 : G65 – G72

    PubMed  CAS  Google Scholar 

  41. Heizer WD, Cleaveland CR, Iver FL (1965) Gastric inactivation of pancreatic supplements. Bull Johns Hopkins Hosp 116:261–270

    PubMed  CAS  Google Scholar 

  42. Di Magno EP (1982) Controversies in the treatment of exocrine pancreatic insufficiency. Dig Dis Sci 27:4811–484

    Google Scholar 

  43. Piubello W, Vantini I, Novelli P, Scuro LA, Benini L, Brocco G, Cavallini G (1982) Gastric secretion, gastroduodenal histological changes and serum gastrin in chronic alcoholic pancreatitis. Am J Gastroenterol 77:105–110

    PubMed  CAS  Google Scholar 

  44. Saunders JHB, Cargill JM, Worsmley KG (1978) Gastric secretion of acid in patients with pancreatic disease. Digestion 17:365–369

    Article  PubMed  CAS  Google Scholar 

  45. Ovensen L, Bendtsen F, Tage-Jensen U, Pedersen NT, Gram BR, Rune SJ (1986) Intraluminal pH in the stomach, duodenum and proximal jejunum in normal subjects and patients with exocrine pancreatic insufficiency. Gastroenterology 90:958–962

    Google Scholar 

  46. Dutta SK, Russell RM, Iber FI (1979) Influence of exocrine pancreatic insufficiency on the intraluminal pH of the proximal small intestine. Dig Dis Sci 24:529–534

    Article  PubMed  CAS  Google Scholar 

  47. Dutta SK, Russell RM, Iber FI (1979) Impaired acid neutralization in the duodenum in pancreatic insufficiency. Dig Dis Sci 44:775–780

    Article  Google Scholar 

  48. Zentler-Munro PL, Fine DR, Batten JC, Northfield TC (1985) Effect of cimetidine on enzyme inactivation, bile acid precipitation, and lipid solubilization in pancreatic steatorrhea due to cystic fibrosis. Gut 26:892–901

    Article  PubMed  CAS  Google Scholar 

  49. Younberger CA, Berardi RR, Howatt WF, Hyneck ML, Amidon GL, Meyer JH, Dressman JB (1987) Comparison of gastrointestinal pH in cystic fibrosis and healthy subjects. Dig Dis Sci 32:472–480

    Article  Google Scholar 

  50. Regan PT, Malagelada JR, Go VLW (1976) Use of cimetidine with oral pancreatic replacement in cystic fibrosis. Clin Res 24:567

    Google Scholar 

  51. Regan PT, Malagelada JR, Di Magno EP, Glanzman SL, Go VLW (1977) Comparative effects of antacids, cimetidine and enteric coating on the therapeutic response to oral enzymes in severe pancreatic insufficiency. N Engl J Med 297:854–858

    Article  PubMed  CAS  Google Scholar 

  52. Regan PT, Malagelada JR, Di Magno EP, Go VLW (1978) Rationale for use of cimetidine in pancreatic insufficiency. Mayo Clin Proc 53:79–83

    PubMed  CAS  Google Scholar 

  53. Gow R, Bradbear R, Francis P, Shepherd R (1981) Comparative study of varying regimens to improve steatorrhoea and creatorrhoea un cystic fibrosis: effectiveness of an enteric-coated preparation with and without antacid and cimetidine. Lancet 2:1071–1074

    Article  PubMed  CAS  Google Scholar 

  54. Lankisch PG, Lembcke B, Goke B, Creutzfeldt W (1983) Therapy of pancreatogenic steatorrhea: does acid protection of pancreatogenic enzymes offer any advantages? Digestion 28:43

    Google Scholar 

  55. Boyle BJ, Long WB, Balistrieri WF, Widzer SJ, Huang N (1980) Effect of cimetidine and pancreatic enzymes on serum and faecal bile acids and fat absorption in cystic fibrosis. Gastroenterology 78:950 – 953

    PubMed  CAS  Google Scholar 

  56. Gullo L, Corinaldesi R, Casadio R (1983) Gastric acid secretion in chronic pancreatitis. Hepatogastroenterology 30:60 – 62

    Google Scholar 

  57. Bianchi Porro G, Dolcini R, Grossi E, Petrillo M, Prada A (1977) Cimetidine in treatment of pancreatic insufficiency. Lancet 2:878 – 879

    Article  PubMed  CAS  Google Scholar 

  58. Lamers CBHW (1986) Omeprazole as adjunct to enzyme replacement treatment in severe pancreatic insufficiency. Br Med J 239:994

    Article  Google Scholar 

  59. Dutta SK, Hubbard VS, Appier M (1988) Critical examination of therapeutic efficacy of a pH-sensitive enteric-coated pancreatic enzyme preparation in the treatment of exocrine pancreatic insufficiency secondary to cystic fibrosis. Dig Dis Sci 33:1237–1244

    Article  PubMed  CAS  Google Scholar 

  60. Guarner L, Rodriguez R, Malagelada JR (1989) Ileal vs. duodenal enzyme activities in treated and untreated pancreatic steatorrhea. Gastroenterology 96: A187

    Google Scholar 

  61. Schneider MU, Knoll-Ruzicka ML, Domschke S, Heptner G, Domschke W (1985) Pancreatic enzyme replacement therapy: comparative effects of conventional enteric-coated microspheric pancreatin and acid-stable fungal enzyme preparations on steatorrhea in chronic pancreatitis. Hepatogastroenterology 32:97–102

    PubMed  CAS  Google Scholar 

  62. Vantini I, Fioretta A, Caliari S, Benini L, Brentegani MT, Castellani G, Bonfante F (1990) Effects of two pancreatic enzyme-containing enteric-coated microsphere preparations on steatorrhea in chronic alcoholic pancreatitis. Curr Ther Res 48:1 – 7

    Google Scholar 

  63. Mitchell EA, Quested C, Marks ER (1987) Comparative trial of Viokase, pancreatin and Pancrease pancrealipase (enteric coated beads) in the treatment of malabsorption in cystic fibrosis. Aust Pediatr J 42:114–117

    Google Scholar 

  64. Stead RJ, Skypala I, Hodson ME, Batten JC (1987) Enteric-coated microspheres of pancreatin in the treatment of cystic fibrosis: comparison with a standard enteric-coated preparation. Thorax 42:533–537

    Article  PubMed  CAS  Google Scholar 

  65. Braggion C, Borgo G, Faggionato P, Mastella G (1987) Influence of antacid and formulation on effectiveness of pancreatic enzyme supplementation in cystic fibrosis. Arch Dis Child 62:349–356

    Article  PubMed  CAS  Google Scholar 

  66. Chazalette JP, Dain MP, Castaigne JP (1988) Efficacy of Pancrease. Crossover comparative study versus Eurobiol in cystic fibrosis. J Pediatr Gastroenterol Nutr 7:46–48

    Article  Google Scholar 

  67. Bouquet J, Sinaasappel M, Neijens HJ (1988) Malabsorption in cystic fibrosis: mechanism and treatment. J Pediatr Gastroenterol Nutr 7:30–35

    Article  Google Scholar 

  68. Ansaldi-Balocco N, Santini B, Sarchi C (1988) Efficacy of pancreatic enzyme supplementation in children with cystic fibrosis: comparison of two preparations by random crossover study of the same patients at two different ages. J Pediatr Gastroenterol Nutr 7:40 –45

    Article  Google Scholar 

  69. Littlewood JM, Kelleher J, Walters MP, Johnson AW (1988) In vivo and in vitro studies of microsphere pancreatic supplements. J Pediatr Gastroenterol Nutr 7:22–29

    Article  Google Scholar 

  70. Carroccio A, Pardo F, Montalto G et al. (1988) Effectiveness of enteric-coated preparations on nutritional parameters in cystic fibrosis. A long term comparative study. Digestion 41:201–206

    Article  PubMed  CAS  Google Scholar 

  71. Beverley DW, Kelleher J, MacDonald A, Littlewood JM, Robinson T, Walters MP (1987) Comparison of four pancreatic extracts in cystic fibrosis. Arch Dis Child 62:564–568

    Article  PubMed  CAS  Google Scholar 

  72. Dobrilla G, Bonoldi MC, Chilovi F (1980) Effect of cimetidine on pancreatic function and disease. In: Torsoli A, Lucchelli PE, Brimblecombe RW (eds) Further experience with H2-receptor antagonists in peptic ulcer disease and progess in histamine research. Ex-cerpta Medica, Amsterdam, pp 148–161

    Google Scholar 

  73. Staub JL, Sarles H, Soule JC, Galmiche JP, Caprow JP (1981) No effect of cimetidine on the therapeutic response to oral enzymes in severe pancreatic insufficiency. N Engl J Med 304:1364–1365

    PubMed  CAS  Google Scholar 

  74. Graham DY (1982) Pancreatic enzyme replacement: effect of antacids or cimetidine. Dig Dis Sci 27:485–490

    Article  PubMed  CAS  Google Scholar 

  75. Scuro LA, Vantini I (1987) Nutritional problems and support in chronic pancreatitis. In: Barbara L (ed) Nutrition and gastrointestinal disease. Raven, New York, pp 273–283

    Google Scholar 

  76. Carroccio A, Pardo F, Montalto G, Iapichino L, Soresi M, Averna MR, Iacono G, Notarbar-tolo A (1992) Use of famotidine in severe exocrine pancreatic insufficiency with persistent maldigestion on enzymatic replacement therapy. A long-term study in cystic fibrosis. Dig Dis Sci 37:1441–1446

    Article  PubMed  CAS  Google Scholar 

  77. Worning H (1980) The effect of enzyme substitution in patients with pancreatic insufficiency. Scand J Gastroenterol 15:529–533

    Article  PubMed  CAS  Google Scholar 

  78. Braga M, Cristallo M, De Franchis R, Mangiagalli A, Agape D, Primignani M, Di Carlo V (1988) Correction of malnutrition and maldigestion with enzyme supplementation in patients with surgical suppression of exocrine pancreatic function. Surg Gynecol Obstet 167:485–492

    PubMed  CAS  Google Scholar 

  79. Braga M, Cristallo M, De Franchis R, Mangiagalli A, Zerbi A, Agape D, Primignani M, Di Carlo V (1989) Pancreatic enzyme replacement therapy in postpancreatectomy patients. Int J Pancreatol 5:37–44

    PubMed  Google Scholar 

  80. Domschke S (1991) Trattamento della steatorrea pancreatica, resistente alia terapia enzimatica sostitutiva convenzionale. In: Dobrilla G, De Pretis G, Piazzi L (eds) Non-responders in gastroenterologia: cause e trattamento. Cortina, Verona, pp 235 – 244

    Google Scholar 

  81. Armbrecht U, Lundell L, Lindstedt G, Stockbrugger RW (1988) The causes of nutrient malassimilation after total gastrectomy with Roux-en-Y reconstruction. Acta Chir Scand 154:37–41

    PubMed  CAS  Google Scholar 

  82. D’Orazio C, Pederzini F, Fratton M, Crema C, Perobelli S, Mastella G (1992) Fattibilità della supplementazione nutrizionale con gastrostomia in fibrosi cistica. In: Bosco A (ed) Atti, P93

    Google Scholar 

  83. Silk DBA (1986) Diet formulation and choice of enterai diet. Gut 27:40– 46

    Article  PubMed  CAS  Google Scholar 

  84. Cristallo M (1986) L’ alimentazione enterale spéciale nelle pancreatiti croniche. Schede Inform 2 :119-122

    Google Scholar 

  85. Dutta SK, Narang A, Nasrallah SM, Iber FL (1981) Evaluation of the efficacy of elemental diet therapy in patients with chronic alcoholic pancreatitis. Gastroenterology 84:1130

    Google Scholar 

  86. Kornowski A, Cosnes J, Gendre JP, Quintrec Y (1992) Enterai nutrition in malnutrition following gastric resection and cephalic pancreaticoduodenectomy. Hepatogastroenterol 39:9–13

    CAS  Google Scholar 

  87. Durie PR, Newth CJ, Forstner GG, Gall DG (1980) Malabsorption of medium-chian triglycérides in infants with cystic fibrosis: correction with pancreatic enzyme supplements. JPediatr 96:862–864

    Article  CAS  Google Scholar 

  88. Di Carlo V, Chiesa R (1984) Intraductal injection of neoprene to suppress pancreatic exocrine secretion in humans. Clinical and metabolic evaluation. Transplant Proc 16: 736–738

    Google Scholar 

  89. Jeejeebhoy KN, Ahmad A, Kozak G (1970) Determination of fecal fats containing both medium and long chain triglycerides and fatty acids. Clin Biochem 3:157–163

    PubMed  CAS  Google Scholar 

  90. Caliari S, Benini L, Brentegani MT, Bonfante F, Castellani G, Fioretta A, Bardelli E, Vantini I (1992) Medium chain triglycerides in exocrine pancreatic insufficiency: evaluation of absorption by chemical methods. Gut 33:22

    Google Scholar 

  91. Griffin SM, Alderson D, Farndon JR (1989) Acid resistant lipase as replacement therapy in chronic pancreatic exocrine insufficiency: a study in dogs. Gut 30:1012–1015

    Article  PubMed  CAS  Google Scholar 

  92. Zentler-Munro PL, Assoufi BA, Balasubramanjan K, Cornell S, Benoliel D, Northfield TC, Hodson ME (1992) Therapeutic potential and clinical efficacy of acid-resistant fungal lipase in the treatment of pancreatic steatorrhea due to cystic fibrosis. Pancreas 7:311–319 (1992)

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1994 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Vantini, I., Benini, L., Caliari, S., Fioretta, A. (1994). What Kind of Pancreatic Extracts To Use?. In: Pederzoli, P., Cavallini, G., Bassi, C., Falconi, M. (eds) Facing the Pancreatic Dilemma. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-79167-3_21

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-79167-3_21

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-58284-7

  • Online ISBN: 978-3-642-79167-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics